ESPR ESPERION THERAPEUTICS INC
2026Q1 · CUSIP 29664W105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
203
Δ holders QoQ
+4
Breadth percentile
Top 46%
Whale holders
99
Δ whales
+5
Inst. holding value
$476M
New positions
39
Closed positions
35
Price momentum (1Q)
-11.8%
Put / Call
5/8
Breadth history (34 quarters)
Past Lit Events & Aftermath 5 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 12% | +24.8% | +11.0% |
| 2024Q2 | Top 10% | +7.1% | -3.1% |
| 2024Q1 | Top 15% | -19.5% | -10.2% |
| 2022Q3 | Top 11% | -18.9% | -77.5% |
| 2018Q1 | Top 8% | +9.1% | +8.3% |
Options Sentiment
Put holders
5
QoQ: 0
Call holders
8
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$0.00
EPS YoY
—
Revenue (TTM)
$0.4B
Revenue YoY
+61.1%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)